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OBJECTIVES: To identify obstetric and maternal factors related to Group B Streptococcus (GBS) coloniza-
tion in pregnant women in Korea.
METHODS: The study was conducted between the years 2006-2008 in four hospitals, Cheil and Eulji hospital 
in Seoul, and Motae and Eulji hospital in Daejeon. We recruited 2,644 pregnant women between 35 to 37 weeks 
of gestation who had visited for antenatal care. Participants completed a questionnaire, and urine, vaginal and 
rectal specimens were obtained and cultured using selective broth media. After delivery, medical records were 
reviewed. 
RESULTS: GBS colonization was significantly associated with hospital, age group, education, frequency of preg-
nancy, and premature rupture of membranes (PROM, more than 18 hours). After adjustment for other vari-
ables, Cheil hospital (odds ratio [OR], 2.05; 95% confidence interval [CI], 1.20-3.52), and the first pregnancy 
(OR, 2.32; 95% CI, 1.12-4.81) remained significant. History of vaginitis showed marginal significance (OR, 
1.50; 95% CI, 0.98-2.29). 
CONCLUSION: To prevent GBS infection of neonates, clinicians should be alert to the potentially higher risk 
of GBS colonization in pregnant women in their first pregnancy, and women with pre  mature rupture of mem-
branes (PROM) (18 hours+) or who have a history of vaginitis.
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INTRODUCTION
Group B streptococcus (GBS, Streptococcus agalactiae) was 
recognized as a major cause of neonatal sepsis and meningitis 
in the 1970s [1], but the first Korean case of GBS neonatal men-
ingitis was not described until 1984. Since then, the number of 
reported cases of neonatal GBS disease in Korea has increased 
steadily [2].
Neonatal sepsis usually develops within 3 days after birth, 
and the most frequent causative organism is GBS [3]. The main 
source of neonatal infection is maternal genital tract coloniza-
tion [4]. GBS is transmitted vertically during labor and delivery, 
and colonization occurs in up to 80% of neonates born to colo-
nized mothers [5]. Maternal streptococcal colonization is also 
associated with increased risk of urinary tract infection and pre-
gnancy complications, such as endometritis [3], chorioamnion-
itis [3,6], preterm birth and intrauterine death [7]. 
Asymptomatic colonization with GBS is common worldwide, 
and depending on the population, between 6.5% [8] and 43.6% 
[9] of pregnant women are colonized with GBS in the vagina 
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or rectum. Maternal GBS colonization varies by population 
characteristics such as age, parity, socio-economic status, geo-
graphic location [10], presence of sexually transmitted diseases 
[11] and sexual behavior [12].
The known risk factors of GBS colonization are as follows; 
delivery at  <37 weeks’ gestation, intrapartum temperature 
≥38.0°C, or rupture of membranes for ≥18 hours [13]. After 
conducting a large population-based study, the Centers for Dis-
ease Control and Prevention (CDC) of the United States cur-
rently recommends screening of all pregnant women for GBS 
between 35 and 37 weeks of gestation [14]. For those with cul-
tures positive for GBS, intrapartum antibiotic prophylaxis (IAP) 
during labor is recommended. Since this strategy was imple-
mented, there has been a 70% reduction in neonatal early-on-
set sepsis [15]. 
Despite declines in early-onset GBS infection in the United 
States, GBS is identified in 40% of early-onset neonatal sepsis 
and remains a leading cause of newborn morbidity and mortal-
ity [14,16]. However, other European countries, which do not 
have high GBS prevalence like USA, do not recommend screen-
ing of all pregnant women for GBS. 
The incidence rate of clinically diagnosed neonatal sepsis in 
Korea of 30.4/1,000 live births [17] is significantly higher than 
the 1.8/1,000 reported for the USA [18]. What percentage of 
this is attributable to GBS is unknown, as GBS screening is not 
a standard of care in Korea.
In 2006-2008, the prevalence of GBS colonization among 
2,624 pregnant women in Seoul and Daejeon in Korea was 8% 
[19]. Risk factors for GBS colonization in pregnant women have 
not been previously studied in Korea. 
To identify risk factors for GBS colonization in pregnant wo-
men, we analyzed the data of 2,644 Korean pregnant women 
who had a screened GBS culture test at 35-37 weeks gestation.
MATERIALS AND METHODS
Subjects
All consenting pregnant women of 35-37 weeks of gestation 
seen in Daejeon, at the Eulji University Hospital or the Motae 
Obstetrics and Gynecology (OBGY) Clinic, or in Seoul, at the 
Eulji General Hospital or Cheil Women’s Hospital between Jan-
uary 2006 and May 2008 who had routine prenatal testing were 
included. 
GBS was cultured and identified in the Departments of Labo-
ratory Medicine of the Eulji hospitals in Seoul and Daejeon and, 
for samples obtained at Cheil Hospital, in the Seoul Clinical 
Laboratory. The laboratory also carried out antimicrobial resis-
tance testing. The Department of Preventive Medicine of Eulji 
University performed GBS laboratory work for the Motae OB-
GY Clinic in Daejeon. The Institutional Review Boards at the 
Eulji (04-08 and 06-25) and Cheil (SCH-IRB-2005-24) hospi-
tals approved the study protocol. Written informed consent 
permitting use of the sample materials and medical records for 
research purposes was obtained from every study participant.
Questionnaire & medical record
Participants completed a self-reported questionnaire, which 
included questions on weight and height before or after preg-
nancy, symptoms during last two weeks, past history, the num-
ber of prenatal examinations, state of health, the presence of 
antibiotics-taking, food intake during last two weeks, smoking, 
alcohol intake, education and household monthly income. We 
reviewed medical records following delivery to collect gravidity, 
complications during the pregnancy, delivery type, the presence 
of ruptured membranes, and duration of membrane rupture. 
Gravidity indicates the total number of times a woman has been 
pregnant, regardless of whether these pregnancies were carried 
to term. The current pregnancy was included in the count.
GBS isolates
GBS collection
Physicians collected vaginal mucus or discharge with a swab 
from the vaginal introitus without inserting a speculum, and 
placed the swab into Stuart’s transport medium. A swab was in-
serted through the anal sphincter, rotated two or three times, 
and placed into a separate container of transport medium. Urine 
samples were self-collected specimens of the first 20 mL of urine. 
All participating laboratories used the same protocols for sam-
ple collection, GBS incubation and identification. Media and 
reagents were purchased by the combined research team and 
distributed to each participating laboratory.
GBS culture
Todd-Hewitt broth supplemented either with gentamicin (8 
μg/mL) and nalidixic acid (15 μg/mL), or with colistin (10 μg/
mL) and nalidixic acid (15 μg/mL) was used to repress the grow-
th of microorganisms other than GBS. Urine samples were cen-
trifuged, and 1 mL of the sedimented sample was placed into 
the selective medium. Rectal and vaginal swabs were removed 
from the transport medium and used to inoculate the selective 
broth medium. Cultures were shaken three or four times to en-
sure adequate mixing of the analyte. The lids of the culture tu-
bes were loosely closed and the cultures incubated, along with 
a negative control, for 18-24 hours at 35-37°C in ambient air 
containing 5% CO2. If the medium in the tubes was still clear 
after 18-24 hours, the cultures were reincubated and inspected 
again at 48 hours. Specimens with evident bacterial growth were 
subcultured on plates containing sheep blood agar, that is, a try-
ptic soy agar with 5% defibrinated sheep blood (TSAII; KO-3
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MED Co., Sungnam, Korea).
GBS identification
We used a catalase test followed by a latex agglutination as-
say (Streptex; Murex Biotech Ltd., Dartford, England) to con-
firm the isolate was GBS.
Statistical analysis
All statistical analyses were done using SPSS version 18.0 
(SPSS Inc., Chicago, IL, USA). The relationship between GBS 
colonization and various risk factors were tested for statistical 
significance using the chi-square test, test for trend, and multi-
ple logistic regression models.
RESULTS
GBS colonization by demographic characteristics
The overall prevalence of GBS colonization among pregnant 
women at 35-37 weeks of gestation was 8.3% (219/2,644). 
Women <25 years had higher rates (14.0%), as did women 
identified at the Cheil hospital (10.7%). GBS colonization in-
creased significantly with increasing education (p=0.034), but 
monthly income was not associated with GBS colonization. 
Smoking, alcohol intake during pregnancy, body mass index 
(BMI) before pregnancy, and subjective health status during 
pregnancy also were not associated with GBS colonization (Ta-
ble 1).
GBS colonization by obstetric characteristics 
Women with one or more children or a history of two or more 
abortions had a significantly lower prevalence of GBS coloniza-
tion (p=0.045 and p=0.034, respectively). This is consistent 
with pregnancy history: higher gravidity was associated with 
lower prevalence of GBS colonization (p=0.009). Delivery 
type, having antibiotics before GBS screening, number of pre-
natal vaginal examinations, and vaginal sonography were not 
related to GBS colonization. Although the association with pre-
mature rupture of membranes (PROM) was not significant, 
membrane rupture of greater than 18 hours was marginally as-
sociated with increased prevalence of GBS colonization (p= 
0.079), (Table 2).
GBS colonization by symptoms and diseases
GBS prevalence was not associated with self-reported history 
for upper respiratory or gastrointestinal symptoms during the 
last 2 weeks. Among complications occurring during the cur-
rent pregnancy, only a history of urinary tract infection was sig-
nificantly related to GBS colonization (p<0.001). Self-reported 
lifetime histories of selected infectious and non-infectious dis-
eases were not significantly associated with GBS colonization 
(Table 3).
GBS colonization by food intake frequency
Regarding the frequency of food intake during last two weeks 
Table 1. Group B streptococcus (GBS) colonization rate by demo-
graphic characteristics of pregnant women (35-37 weeks) in Korea 
(2006-2008) 
Subjects (n)  GBS positives (%)  p-value* 
Hospital <0.001 
Daejeon Eulji  326 4.9
Seoul Eulji  298 5.7
Motae  673 6.2
Cheil  1,347 10.7
Age (yr)  0.070 
<25  93 14.0 
25-29  848 6.7
30-34  1,236 8.5
35+ 390 9.0 
Missing  77 11.7
BMI before pregnant (kg/m
2) 0.868
<20  1,042 8.2
20-24  1,291 8.2
25+ 223 7.2
Missing  88 13.6
Health status during pregnancy  0.837
Healthy  1,743 8.4
Moderate  725 7.9
Not good  118 9.3
Missing  58 8.6
Smoking during pregnancy  0.638
Never  1,956 8.3
Secondhand  647 8.3
Yes  5 20.0 
Missing  36 5.6
Alcohol during pregnancy  0.681
Never  2,297 8.4
Yes  311 7.7
Missing  36 5.6
Education  0.034
† 
High school or less  666 6.8
College  565 7.3
University or more  1,326 9.4
Missing  87 10.3
Household monthly income (US$)  0.186
<3,000  1,189 7.5
3,000-3,999  375 9.3
4,000-4,999  303 11.2
5,000+ 263 8.4  
Missing  514 7.6
Total  2,644  8.3 
BMI, body mass index.
1US$=1,000 Korea Won.
*p-value obtained by chi-square test; 
†p-value obtained by trend test. 4
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before the GBS test, drinking milk six or more time was signifi-
cantly associated with GBS colonization (p=0.043). However 
fruits, vegetables, egg, chicken, pork, beef, raw fish and cooked 
fish, were not significantly associated with GBS colonization 
(Table 4).
Risk factors for GBS colonization after adjustment using 
a multiple logistic regression model
All variables significant in the univariate analysis were includ-
ed in a multiple regression model. After adjustment for hospi-
tal, age, gravidity, history of vaginitis and cystitis, associations 
with education level and frequency of drinking milk were no 
longer statistically significant. History of urinary tract infection 
and the duration of PROM over 18 hours were not included in 
the model because the sample size of urinary tract infection was 
very small (n=15) and only PROM positives have a duration of 
PROM. 
Following adjustment, Cheil hospital (OR, 2.05; 95% CI, 
1.20-3.52) and the first pregnancy (OR, 2.32; 95% CI, 1.12-
4.81) were significantly associated with GBS colonization (Mo-
tae hospital, which is a private clinic for obstetrics, does not re-
cord abortions, so the cases from this hospital were not includ-
ed in multiple regression analysis.). The history of vaginitis and 
cystitis were marginally significant, however, vaginitis increased 
colonization and cystitis decreased colonization. Women under 
25 years had a higher colonization rate compared to women 35 
years and older, but women 25 to 29 years old had a signifi-
cantly lower prevalence. An interaction between age group and 
gravidity was not statistically significant; the interaction term 
was not included in the final model (Table 5). 
DISCUSSION
Among 2,644 pregnant Korean women screened between 
35-37 weeks gestation, GBS colonization was significantly high-
er in the first pregnancy, and in one hospital. 
Women less than 25 years of age had a higher prevalence of 
colonization, but there was no linear trend with age, and young-
er age was not a significant risk factor following adjustment. An 
association between age and gravidity and GBS colonization 
has been reported in some studies but not others; several stud-
ies [20-22] found no significant differences in colonization rates 
by age or parity, while others report associations with increas-
ing gravidity [23], young age [24] and lower parity [10,24,25]. 
In other countries, young maternal age is a risk factor for ear-
ly-onset neonatal sepsis [14,24,26,27] and infants who are 
born of teenagers show higher rates of GBS diseases [26]. In 
this study, only 3.5% of study participants were less than 25 
years old; therefore, if an association with maternal age exists 
in Korea, it is swamped by other variables in our dataset.
In contrast to other reports where GBS prevalence is higher 
among those with lower socioeconomic status [28] and educa-
tion [10], we observed higher colonization rates among women 
who are socially advantaged with a higher education. However, 
these associations were not significant following adjustment be-
Table 2. Group B streptococcus (GBS) colonization rate by obstet-
ric characteristics of pregnant women (35-37 weeks) in Korea (2006- 
2008)
Subjects (n)  GBS positives (%)  p-value* 
No. of living baby 0.045
0 1,724 8.8
1+  870 6.6
Missing 50 20.0 
No. of abortion(s)  0.034
0 1,243 9.1
1 453 10.2
2+  229 4.4
Missing 719 7.0 
Gravidity  0.009
† 
1 853  10.4
2-3  891  8.0 
4+  181  5.0 
Missing 719 7.0 
Antibiotics 2 weeks before test  0.567
‡ 
No  2,573 8.3
Yes  35 8.6
Missing  36 5.6
No. of prenatal vaginal exam(s) 0.407
0 193 9.8
1-2  804 7.0 
3-4  126 7.9
5+  84 10.7
Missing  1,437 8.7
No. of prenatal vaginal sonogram(s)  0.210 
0 45 6.7
1-2  662 8.8
3-4  441 5.7
5+ 223 9.4
Missing  1,273 8.8
Delivery type  0.358
Vaginal  1,896 7.9
Cesarean section  679 9.0 
Missing  69 13.0 
Premature rupture of membrane (PROM)  0.139
No  2,057 7.8
Yes  511 9.8
Missing  76 11.8
Duration of PROM  0.079
<18 hours  308 7.5
18 hours+ 134 12.7
Missing 69 14.5
p-value obtained by *chi-square test; 
†trend test; 
‡Fisher’s exact test. 5
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cause a higher education was related to younger age, primi-
gravida, and Cheil hospital. 
Risk factors for colonization by serotype of GBS were ana-
lyzed. After adjustment, Cheil hospital (OR, 7.51; 95% CI, 
1.02-55.46) and a history of vaginitis (OR, 2.18; 95% CI, 1.00-
4.75) were significantly associated with serotype V GBS coloni-
zation. For other serotypes, there were no significant variables 
in multiple logistic regression models (data not shown). 
As the GBS is a common colonizer of the genital and rectal 
area, the ascent of GBS from the vagina to the amniotic fluid 
likely increases the risk of neonatal infection. Therefore, fre-
quent vaginal exams [6,29] or vaginal sonogram might increase 
risk of PROM or preterm labor. In this study we found that a 
high frequency of vaginal sonography (3 times or more) signifi-
cantly increased risk of PROM (OR, 1.49; 95% CI, 1.13-1.97) 
compared to having a sonogram 0-2 times (data not shown). 
However, this risk was not significantly increased among wom-
en colonized with GBS. 
Even though PROM was not related to significantly higher 
GBS colonization rates, among PROM mothers, PROM of 18 
hours or more duration was marginally associated with a high 
prevalence of GBS colonization (p=0.079). 
Among the symptoms during last two weeks before test, there 
were no related symptoms found. Among diseases during preg-
nancy, urinary tract infection was shown as a significant risk 
factor. However, the prevalence of urinary tract infection was 
very low - 0.5% (15/2,644). 
Among four participating hospitals, Cheil hospital showed 
high rates of GBS colonization, which was still significant even 
in a multiple regression analysis. Cheil hospital is well known 
as a maternity hospital, and has the greatest number of deliver-
Table 3. Group B streptococcus (GBS) colonization rate (%) by symptoms during last two weeks and diseases in pregnant women (35-37 
weeks) in Korea (2006-2008) 
Yes No Missing
p-value*
n  GBS (%)  n  GBS (%)  n  GBS (%) 
Symptoms 
Influenza-like illness 560 8.6 2,048 8.3 36 5.6 0.808
Fever  20 5.0  2,588 8.3 36 5.6 0.589
Sore throat  312 7.7 2,296 8.4 36 5.6 0.668
Vomiting  103 8.7 2,505 8.3 36 5.6 0.876
Diarrhea  278 10.4 2,330 8.1 36 5.6 0.178
Complications during pregnancy 
Hypertension 34 2.9 2,555 8.2 55 14.5 0.264
Diabetes 70 8.6 2,519 8.1 55 14.5 0.896
Urinary tract infection 15 40.0  2,574 8.0  55 14.5 <0.001 
Myoma  49 8.2 2,540 8.1 55 14.5 0.997
Oligohydramnios  138 8.7 2,451 8.1 55 14.5 0.810 
Polyhydramnios  5 0.0  2,584 8.2 55 14.5 0.356
Diseases in lifetime 
Cystitis  285  6.7  2,323  8.5  36 5.6 0.470 
Nephritis  118  6.8  2,490  8.4  36  5.6  0.689 
Vaginitis  417  10.1  2,191  8.0  36 5.6 0.307 
Herpes infection  34  14.7  2,574  8.2  36 5.6 0.332 
Diabetes  85 9.4 2,523 8.3 36 5.6 0.711
Hypertension 25 16.0  2,583 8.2 36 5.6 0.162
Tuberculosis  78 11.5 2,530 8.2 36 5.6 0.296
Viral hepatitis  90 5.6 2,518 8.4 36 5.6 0.334
Gonorrhea 8 0.0  2,600 8.3 36 5.6 0.393
*p-value obtained by chi-square test.
Table 4. Group B streptococcus (GBS) colonization rate by frequen-
cy of food intake during last two weeks in pregnant women (35-37 
weeks) in Korea (2006-2008) 
0-1 2-5  6+  p- 
value* n  GBS (%)  n GBS (%)  n GBS (%) 
Fruits  44 4.5 728 8.1 1,812 8.5 0.624
Vegetables  175 7.4 1,320 7.7 1,029 9.4 0.301
Milk  300 7.7 881 6.7 1,379 9.6 0.043
Egg  415 9.2 1,449 7.9 677 8.9 0.598
Chicken  1,398 8.9 1,050 7.7 64 7.8 0.548
Beef  1,134 8.1 1,265 8.1 124 11.3 0.460
Pork  732 7.2 1,660 8.9 144 7.6 0.374
Raw fish  2,237 8.4 223 8.1 10 0.0 0.620
Cooked fish  952 8.3 1,402 8.3 183 9.8 0.766
*p-value obtained by chi-square test.6
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ies in Korea; some 8,000 women give birth there each year. We 
could not explain why the GBS colonization rate is high in Cheil 
hospital in this study. In comparisons of four hospitals, there 
were no significant differences, except GBS colonization rates.
In the U.S in 1996, CDC recommended the use of one of two 
prevention strategies for decreasing GBS disease: a screening-
based method, where IAP is offered to women identified as 
GBS carriers through prenatal screening cultures collected at 
35-37 weeks’ gestation and to women who develop premature 
onset of labor or rupture of membranes at less than 37 weeks’ 
gestation, and the other is the risk-based method, where IAP is 
provided to women who develop one or more risk conditions 
at the time of labor or membrane rupture [13]. Subsequently, 
in 2002, CDC recommended that all pregnant women be screen-
ed at 35-37 weeks’ gestation for vaginal and rectal GBS coloni-
zation, and if the result of GBS culture is not known at the on-
set of labor, IAP should be administered to women with any of 
the following risk factors (gestation  <37 weeks, duration of 
membrane rupture ≥18 hours, or a temperature of ≥38.0°C) 
[14]. In the revised guidelines of 2010, the principles were not 
changed [30].
In the current study, 45% of the pregnant women had one or 
two risk factors (<25 years, and the first pregnancy); the GBS 
colonization rate was 10.8% in risk group. However, the GBS 
colonization rate for the no-risk group was 7.3%, suggesting 
that a better understanding of GBS risk factors in Korea is in 
order before recommending a risk-based strategy. 
Table 5. Risk of Group B streptococcus (GBS) colonization in pregnant women (35-37 weeks) in Korea (2006-2008) by using a multiple lo-
gistic regression model (n=1,907) 
Variables of regression model  GBS positives n (%)  GBS negatives  n (%)  Unadjusted OR  Adjusted OR  95% CI  p-value 
Hospital
Daejeon Eulji  16 (5.2) 291 (94.8) 1.00  1.00 
Seoul Eulji  16 (5.6)  268 (94.4)  1.09 1.02  0.50-2.09 0.960 
Cheil  137 (10.4)  1,179 (89.6)  2.11  2.05  1.20-3.52  0.009 
Age (yr)
<25  9 (18.4)  40 (81.6)  2.09  1.83  0.77-4.03  0.181 
25-29  41 (7.4) 514 (92.6) 0.74 0.58  0.35-0.94  0.028 
30-34  86 (8.9)  878 (91.1)  0.91 0.76  0.49-1.17  0.208 
35+  33 (9.7)  306 (90.3)  1.00  1.00 
Gravidity 
4+  9 (5.0)  172 (95.0)  1.00  1.00 
2-3  71 (8.0) 817 (92.0) 1.66  1.62  0.79-3.35  0.192 
1 89 (10.6)  749 (89.4)  2.27  2.32  1.12-4.81  0.023 
Vaginitis 
No 139 (8.5)  1,496 (91.5)  1.00  1.00 
Yes 30 (11.8)  224 (88.2)  1.55 1.50  0.98-2.29  0.063 
Cystitis 
No 156 (9.3)  1,521 (90.7)  1.35  1.76  0.97-3.18  0.062
Yes 13 (6.1)  199 (93.9)  1.00  1.00
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